Efficacy of Janus kinase inhibitors in rheumatoid arthritis

被引：0
|
作者：
Camille Langbour
Jessica Rene
Philippe Goupille
Guillermo Carvajal Alegria
机构：
[1] CHRU de Tours,Service de Rhumatologie
[2] Université de Tours,undefined
来源：
Inflammation Research | 2023年 / 72卷
关键词：
Tofacitinib; Upadacitinib; Baricitinib; Filgotinib; Rheumatoid arthritis; Efficacy; Predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1121 / 1132
页数：11
相关论文
共 50 条
  • [31] Janus kinase inhibitors: efficacy and safety
    Cohen, Stanley
    Reddy, Virginia
    CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (06) : 429 - 434
  • [32] Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis
    Yun-Wen Chen
    Hsin-Hua Chen
    Wen-Nan Huang
    Jun-Peng Chen
    Yi-Hsing Chen
    Yi-Ming Chen
    Clinical Rheumatology, 2024, 43 : 117 - 128
  • [33] Persistence of Janus-kinase (JAK) inhibitors in rheumatoid arthritis: Australia wide study
    Scheepers, Lieke
    Yang, Yifei
    Chen, Yi Lung
    Jones, Graeme
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 64
  • [34] Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?
    Martinez-Molina, Cristina
    Feliu, Anna
    Park, Hye S.
    Juanes, Ana
    Diaz-Torne, Cesar
    Vidal, Silvia
    Corominas, Hector
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [35] Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
    Kotyla, Przemyslaw J.
    Islam, Md Asiful
    Engelmann, Malgorzata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 17
  • [36] Pharmacokinetic review of janus kinase inhibitors and its clinical implications for the management of rheumatoid arthritis
    Chandrashekara, S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (08) : 741 - 748
  • [37] Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
    Temmoku, Jumpei
    Miyata, Masayuki
    Suzuki, Eiji
    Sumichika, Yuya
    Saito, Kenji
    Yoshida, Shuhei
    Matsumoto, Haruki
    Fujita, Yuya
    Matsuoka, Naoki
    Asano, Tomoyuki
    Sato, Shuzo
    Migita, Kiyoshi
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [38] Changes in the cholesterol profile of patients with rheumatoid arthritis treated with biologics or Janus kinase inhibitors
    Koh, Jung Hee
    Lee, Bong-Woo
    Kim, Wan-Uk
    JOURNAL OF RHEUMATIC DISEASES, 2023, 30 (04): : 234 - 242
  • [39] Outcomes in Patients with Rheumatoid Arthritis Initiating Therapy with Etanercept, Adalimumab, or Janus Kinase Inhibitors
    Pappas, Dimitrios
    O'Brien, Jacqueline
    Guo, Lin
    Shan, Ying
    Baker, Joshua
    Kricorian, Gregory
    Stryker, Scott
    Collier, David
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 856 - 857
  • [40] Outcomes in Patients with Rheumatoid Arthritis Initiating Monotherapy with Etanercept, Adalimumab, or Janus Kinase Inhibitors
    Pappas, Dimitrios
    O'Brien, Jacqueline
    Kelleman, Mike
    Guo, Lin
    Shan, Ying
    Baker, Joshua
    Kricorian, Greg
    Stryker, Scott
    Collier, David
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2798 - 2800
12345